GSK Urges FDA Crackdown On Unsubstantiated Weight-Loss Claims

FDA should take stricter enforcement action against marketers of weight-loss supplements who continue to use unsubstantiated product claims following receipt of a warning letter, according to GlaxoSmithKline Consumer Healthcare